Article | n Repeats | n Patients* | PRNP codon 129† | Age at onset (years) | Disease duration (months)‡ |
---|---|---|---|---|---|
*Patients with mutation analysis, or patients with autopsy and a blood relative with mutation analysis, or patients with mutation analysis as well as autopsy, are reported. †M, methionine; V, valine; the numbers in superscript denote the number of carriers. ‡For patients alive at time of publication, the disease duration is indicated with a “+” sign. §Not included in the analyses because of missing age at onset and duration for each patient. n.a., not available. | |||||
Laplanche29 | 1 | 1 | MM | 73 | 4 |
Goldfarb19 | 2 | 2 | MM | 58/75 | 3/156+ |
Van Harten20 | 2 | 1 | VV | 61 | 84 |
This article | 2 | 1 | MV | 59 | 120+ |
Laplanche29 | 4 | 1 | VV | 82 | 4 |
Rossi36 | 4 | 1 | MM | 65 | 6 |
Campbell21 | 4 | 1 | MM | 56 | 2 |
Yanagihara9 | 4 | 1 | MM | 56 | 5 |
Goldfarb26 | 5 | 2 | n.a. | 31/45 | 60/180 |
Cochran23 | 5 | 3 | MM | 26 to 44 | 84 to 168+ |
Skworc37 | 5 | 3 | MV | 51 to 61 | 4 to 96 |
Oda33 | 6 | 3 | MM | 33 to 34 | 60 to 84+ |
Capellari22 | 6 | 2 | MV | 38 | 48/120 |
Nicholl32 | 6 | 2 | n.a. | 34/46 | 3/60 |
Collinge,24 Poulter35 | 6 | 13 | MM8/MV3 | 22 to 47 | 24 to 156 |
Goldfarb26 | 7 | 3 | n.a. | 23 to 35 | 120 to 156 |
Dermaut40 | 7 | 2 | MM | 24/31 | 132 |
Goldfarb27 | 8 | 3 | MM | 35 to 54 | 3 to 24 |
Laplanche30 | 8 | 5 | MM | 21 to 32 | 36 to 144+ |
Van Gool38 | 8 | 3 | MV1/VV2 | 21 to 54 | 12+ to 72 |
Moore,31 Xiang42§ | 8 | 4 | n.a. | 23 to 41 | n.a. |
Owen34 | 9 | 1 | n.a. | 53 | 30 |
Krasemann28 | 9 | 1 | MM | 32 | 72+ |